These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30288999)

  • 1. Women's Experiences of Day-and-Night Closed-Loop Insulin Delivery During Type 1 Diabetes Pregnancy.
    Farrington C; Stewart Z; Hovorka R; Murphy H
    J Diabetes Sci Technol; 2018 Nov; 12(6):1125-1131. PubMed ID: 30288999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiences of closed-loop insulin delivery among pregnant women with Type 1 diabetes.
    Farrington C; Stewart ZA; Barnard K; Hovorka R; Murphy HR
    Diabet Med; 2017 Oct; 34(10):1461-1469. PubMed ID: 28631849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review.
    Farrington C
    Diabet Med; 2018 Apr; 35(4):436-449. PubMed ID: 29247547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial.
    Stewart ZA; Wilinska ME; Hartnell S; O'Neil LK; Rayman G; Scott EM; Barnard K; Farrington C; Hovorka R; Murphy HR
    Diabetes Care; 2018 Jul; 41(7):1391-1399. PubMed ID: 29535135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes.
    Stewart ZA; Wilinska ME; Hartnell S; Temple RC; Rayman G; Stanley KP; Simmons D; Law GR; Scott EM; Hovorka R; Murphy HR
    N Engl J Med; 2016 Aug; 375(7):644-54. PubMed ID: 27532830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated Insulin Delivery in Adults.
    Boughton CK; Hovorka R
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):167-178. PubMed ID: 31980116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting.
    Barnard KD; Wysocki T; Thabit H; Evans ML; Amiel S; Heller S; Young A; Hovorka R;
    Diabet Med; 2015 May; 32(5):601-8. PubMed ID: 25615888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced burden of diabetes and improved quality of life: Experiences from unrestricted day-and-night hybrid closed-loop use in very young children with type 1 diabetes.
    Musolino G; Dovc K; Boughton CK; Tauschmann M; Allen JM; Nagl K; Fritsch M; Yong J; Metcalfe E; Schaeffer D; Fichelle M; Schierloh U; Thiele AG; Abt D; Kojzar H; Mader JK; Slegtenhorst S; Ashcroft N; Wilinska ME; Sibayan J; Cohen N; Kollman C; Hofer SE; Fröhlich-Reiterer E; Kapellen TM; Acerini CL; de Beaufort C; Campbell F; Rami-Merhar B; Hovorka R;
    Pediatr Diabetes; 2019 Sep; 20(6):794-799. PubMed ID: 31140654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Closing the Loop in Adults, Children and Adolescents With Suboptimally Controlled Type 1 Diabetes Under Free Living Conditions: A Psychosocial Substudy.
    Barnard KD; Wysocki T; Ully V; Mader JK; Pieber TR; Thabit H; Tauschmann M; Leelarathna L; Hartnell S; Acerini CL; Wilinska ME; Dellweg S; Benesch C; Arnolds S; Holzer M; Kojzar H; Campbell F; Yong J; Pichierri J; Hindmarsh P; Heinemann L; Evans ML; Hovorka R
    J Diabetes Sci Technol; 2017 Nov; 11(6):1080-1088. PubMed ID: 28367636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is an artificial pancreas (closed-loop system) for Type 1 diabetes effective?
    Boughton CK; Hovorka R
    Diabet Med; 2019 Mar; 36(3):279-286. PubMed ID: 30183096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "It Is Definitely a Game Changer": A Qualitative Study of Experiences with In-home Overnight Closed-Loop Technology Among Adults with Type 1 Diabetes.
    Hendrieckx C; Poole LA; Sharifi A; Jayawardene D; Loh MM; Horsburgh JC; Bach LA; Colman PG; Kumareswaran K; Jenkins AJ; MacIsaac RJ; Ward GM; Grosman B; Roy A; O'Neal DN; Speight J
    Diabetes Technol Ther; 2017 Jul; 19(7):410-416. PubMed ID: 28537437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptability of Closed Loop During Labor, Delivery, and Postpartum: A Secondary Analysis of Data from Two Randomized Crossover Trials in Type 1 Diabetes Pregnancy.
    Stewart ZA; Yamamoto JM; Wilinska ME; Hartnell S; Farrington C; Hovorka R; Murphy HR
    Diabetes Technol Ther; 2018 Jul; 20(7):501-505. PubMed ID: 29958022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative Study.
    Lawton J; Blackburn M; Rankin D; Allen JM; Campbell FM; Leelarathna L; Tauschmann M; Thabit H; Wilinska ME; Elleri D; Hovorka R
    Diabetes Technol Ther; 2019 Mar; 21(3):119-127. PubMed ID: 30720338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faster insulin action is associated with improved glycaemic outcomes during closed-loop insulin delivery and sensor-augmented pump therapy in adults with type 1 diabetes.
    Ruan Y; Thabit H; Leelarathna L; Hartnell S; Wilinska ME; Tauschmann M; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Evans ML; Pieber TR; Arnolds S; Hovorka R;
    Diabetes Obes Metab; 2017 Oct; 19(10):1485-1489. PubMed ID: 28371223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home.
    Renard E; Farret A; Kropff J; Bruttomesso D; Messori M; Place J; Visentin R; Calore R; Toffanin C; Di Palma F; Lanzola G; Magni P; Boscari F; Galasso S; Avogaro A; Keith-Hynes P; Kovatchev B; Del Favero S; Cobelli C; Magni L; DeVries JH;
    Diabetes Care; 2016 Jul; 39(7):1151-60. PubMed ID: 27208331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
    Emami A; Willinska ME; Thabit H; Leelarathna L; Hartnell S; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Pieber TR; Arnolds S; Evans ML; Hovorka R
    Diabetes Technol Ther; 2017 Jul; 19(7):433-437. PubMed ID: 28463010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes.
    Kravarusic J; Aleppo G
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):37-55. PubMed ID: 31980120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing Diabetes in Pregnancy Before, During, and After COVID-19.
    Murphy HR
    Diabetes Technol Ther; 2020 Jun; 22(6):454-461. PubMed ID: 32396397
    [No Abstract]   [Full Text] [Related]  

  • 19. Who Should Access Closed-Loop Technology? A Qualitative Study of Clinician Attitudes in England.
    Farrington C; Hovorka R; Murphy HR
    Diabetes Technol Ther; 2020 May; 22(5):404-410. PubMed ID: 31913061
    [No Abstract]   [Full Text] [Related]  

  • 20. Real-world lived experience of older adults with type 1 diabetes after an automated insulin delivery trial.
    Kubilay E; Trawley S; Ward GM; Fourlanos S; Colman PG; McAuley SA
    Diabet Med; 2024 Apr; 41(4):e15264. PubMed ID: 38073128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.